# RWE Diabetes Readmission Analysis

[![Python](https://img.shields.io/badge/Python-3.9+-blue.svg)](https://python.org)
[![Data](https://img.shields.io/badge/Data-UCI%20ML-orange.svg)](https://archive.ics.uci.edu/ml/datasets/Diabetes+130-US+hospitals+for+years+1999-2008)
[![License](https://img.shields.io/badge/License-CC%20BY%204.0-green.svg)](https://creativecommons.org/licenses/by/4.0/)

**Real-World Evidence analysis identifying risk factors for 30-day hospital readmission in 101,766 diabetic patient encounters.**

---

## ðŸ“Š Results at a Glance

| Metric | Value |
|--------|-------|
| **Sample Size** | 101,766 encounters |
| **Outcome Rate** | 11.2% (30-day readmission) |
| **Statistical Method** | Multivariable Logistic Regression |
| **Primary Finding** | Age â‰¥70 years: OR 1.21 (95% CI: 1.10â€“1.33) |

### Significant Risk Factors

| Factor | Odds Ratio | 95% CI | P-value |
|--------|-----------|--------|---------|
| Age 70â€“80 years | **1.21** | 1.10â€“1.33 | <0.001 |
| Age 80â€“90 years | **1.18** | 1.05â€“1.32 | 0.005 |
| Number of medications | 1.01 | 1.00â€“1.02 | 0.02 |

> ðŸ“– **[View complete analysis with Forest Plot â†’](notebooks/02_diabetes_rwe.ipynb)**

---

## Study Design

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  POPULATION     Adults with diabetes (130 US hospitals)        â”‚
â”‚  TIMEFRAME      1999â€“2008                                       â”‚
â”‚  EXPOSURE       Age, gender, medications, procedures, LOS       â”‚
â”‚  OUTCOME        Hospital readmission within 30 days (binary)    â”‚
â”‚  ANALYSIS       Logistic regression, adjusted for confounders   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## Repository Structure

```
rwe-diabetes-readmission/
â”œâ”€â”€ notebooks/
â”‚   â””â”€â”€ 02_diabetes_rwe.ipynb   â† Full analysis with outputs
â”œâ”€â”€ src/
â”‚   â””â”€â”€ fetch_data.py           â† Reproducible UCI data download
â”œâ”€â”€ docs/
â”‚   â””â”€â”€ results.md              â† Detailed results summary
â”œâ”€â”€ requirements.txt
â””â”€â”€ README.md
```

---

## Quick Start

```bash
# 1. Clone
git clone https://github.com/YOUR_USERNAME/rwe-diabetes-readmission.git
cd rwe-diabetes-readmission

# 2. Install dependencies
pip install -r requirements.txt

# 3. Run analysis (notebook has pre-computed outputs)
jupyter notebook notebooks/02_diabetes_rwe.ipynb
```

---

## Key Insights

1. **Age is the strongest predictor** â€” Patients aged 70+ have 18â€“21% higher odds of early readmission
2. **Medication count matters** â€” Each additional medication slightly increases readmission risk
3. **More procedures = lower risk** â€” Possibly indicates more thorough inpatient care
4. **No gender difference** â€” Male and female patients show similar readmission patterns

---

## Limitations

| Limitation | Implication |
|------------|-------------|
| Observational design | Association â‰  causation |
| Historical data (1999â€“2008) | Practice patterns may differ today |
| Missing variables | Weight (97%), payer (40%) unavailable |
| Binary outcome | Severity/urgency not captured |

---

## Data Source

**Diabetes 130-US Hospitals for Years 1999â€“2008**  
UCI Machine Learning Repository (ID: 296)

- ðŸ“„ [Dataset Documentation](https://archive.ics.uci.edu/ml/datasets/Diabetes+130-US+hospitals+for+years+1999-2008)
- ðŸ“š [Original Publication](https://doi.org/10.1155/2014/781670) â€” Strack et al., BioMed Research International, 2014
- âš–ï¸ License: CC BY 4.0

---

## Skills Demonstrated

- **RWE/Epidemiology**: Cohort definition, outcome measurement, confounder adjustment
- **Statistical Analysis**: Logistic regression, odds ratio interpretation, confidence intervals
- **Data Engineering**: Reproducible ETL from UCI repository
- **Communication**: Clear visualization of clinical findings

---

> *This project demonstrates competencies in pharmacovigilance, clinical research, and health data science.*
